| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 129.89B | 139.12B | 150.02B | 200.83B | 151.99B |
| Gross Profit | 31.33B | 49.81B | 60.96B | 82.22B | 44.65B |
| EBITDA | 29.79B | 46.26B | 56.31B | 74.53B | 40.03B |
| Net Income | 8.92B | 14.43B | 20.14B | 33.82B | 16.44B |
Balance Sheet | |||||
| Total Assets | 452.17B | 358.55B | 354.28B | 295.80B | 288.70B |
| Cash, Cash Equivalents and Short-Term Investments | 38.23B | 38.51B | 37.70B | 45.27B | 45.83B |
| Total Debt | 173.77B | 79.67B | 77.94B | 75.01B | 98.42B |
| Total Liabilities | 310.97B | 225.54B | 235.94B | 167.71B | 192.21B |
| Stockholders Equity | 71.32B | 82.59B | 72.69B | 94.74B | 68.19B |
Cash Flow | |||||
| Free Cash Flow | 2.29B | 5.27B | -2.02B | 35.27B | 25.74B |
| Operating Cash Flow | 17.01B | 22.34B | 16.17B | 53.45B | 36.18B |
| Investing Cash Flow | -14.35B | -9.73B | -12.20B | -12.63B | -4.83B |
| Financing Cash Flow | -6.51B | -12.39B | -32.51B | -43.27B | -8.04B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$1.15T | 17.31 | 13.43% | 8.97% | -6.04% | -7.87% | |
72 Outperform | HK$10.34B | -9.03 | 6.97% | ― | -20.89% | -97.28% | |
71 Outperform | HK$13.95B | 23.58 | 3.92% | 9.28% | -0.02% | -59.00% | |
67 Neutral | HK$239.02B | 4.20 | 11.37% | 4.59% | -21.82% | -20.14% | |
66 Neutral | HK$18.21B | 7.72 | 10.90% | 9.92% | -6.35% | -57.55% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
63 Neutral | HK$203.77B | 9.73 | 11.62% | 8.02% | 7.29% | -48.69% |